The Latest Breaking News from the 5th Circuit

On April 21, 2023, the U.S. Supreme Court ruled that the abortion pill mifepristone, which is used in more than half of all abortions in the U.S., could remain accessible without restrictions – at least for now. The decision is temporary, however, buying time as an appeals court weighs the…

Mifepristone will remain on the market for now with no changes to how it can be prescribed.

The legal challenge to mifepristone now returns to the 5th U.S. Circuit Court of Appeals in New Orleans.

WASHINGTON — The Supreme Court gave itself more time on a decision expected Wednesday about a commonly used abortion drug, extending until Friday a temporary pause on a lower court ruling that would restrict availability of mifepristone.

The Supreme Court extended until Friday a temporary pause on a lower court ruling that would restrict availability of mifepristone.

WASHINGTON – President Joe Biden has picked a longtime federal magistrate in Dallas for the influential 5th U.S. Circuit Court of Appeals.

WASHINGTON — The Supreme Court temporarily paused through at least Wednesday a court order that would have restricted a commonly used abortion drug nationwide in a brief order issued Friday afternoon.

An early April 2023 decision by a U.S. district judge in Texas to reverse 23 years of approval of the abortion pill mifepristone has sparked explosive debate.

WASHINGTON — The Justice Department and a pharmaceutical company on Friday asked the Supreme Court to intervene in the court fight over a commonly used abortion drug in order to keep a court ruling restricting availability of the drug from taking effect this weekend.

Government says restrictions on mifepristone would deny people ‘lawful access’ to drug deemed safe by US regulators.

The ruling comes after a federal judge in Texas suspended the FDA's 2000 approval of mifespristone, a drug used for medication abortions.